Skip to Main Content
Insider Trading

Last Updated: 4 days, 17 hours ago

Roger Md Medel has an estimated net worth of at least $23.4 million*, as of April 23, 2025. They own 747,930 shares of MD stock. They have sold 500,000 shares of MD stock since 2021, for an estimated $13.9 million.

Roger Md Medel $MD SEC Form 4 Insider Trading

Roger Md Medel has filed a total of 12 insider trades in $MD since 2021. Their most recent trade was a sale of 40,107 shares, made on Jan 11, 2022. Their largest trade was a sale of 100,000 shares, made on Jul 01, 2021. We estimate that they now own 747,930 shares of $MD, worth an estimated $9.5 million.



Insider Trading at $MD

There have been a total of 31 insider trades reported at $MD since 2021, with 0 shares purchased and 754,888 shares sold. The most active insider traders in $MD stock have been James D Swift, C Marc Richards, and John C Pepia. The most recent trade was a sale of 27,600 shares reported by MARK S ORDAN (None), made on Nov 13, 2024.



History of Insider Stock Trades by Roger Md Medel

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
MD logo MD Sale 40,107 Jan 11, 2022 Jan. 11, 2022, 7 p.m.
MD logo MD Sale 59,893 Jan 10, 2022 Jan. 11, 2022, 7 p.m.
MD logo MD Sale 12,639 Jan 05, 2022 Jan. 6, 2022, 8 p.m.
MD logo MD Sale 6,564 Dec 31, 2021 Jan. 3, 2022, 8 p.m.
MD logo MD Sale 87,361 Jan 04, 2022 Jan. 3, 2022, 8 p.m.
MD logo MD Sale 45,397 Dec 30, 2021 Dec. 30, 2021, 6:13 p.m.
MD logo MD Sale 25,000 Dec 29, 2021 Dec. 29, 2021, 6:31 p.m.
MD logo MD Sale 66,868 Dec 27, 2021 Dec. 29, 2021, 6:31 p.m.
MD logo MD Sale 44,514 Dec 28, 2021 Dec. 29, 2021, 6:31 p.m.
MD logo MD Sale 10,387 Oct 28, 2021 Oct. 28, 2021, 8 p.m.
MD logo MD Sale 1,270 Oct 04, 2021 Oct. 5, 2021, 8 p.m.
MD logo MD Sale 100,000 Jul 01, 2021 July 1, 2021, 8 p.m.




$MD Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.